{"id":1350765,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis:A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-19","captureTimestamp":"2026-02-19T20:06:19.149000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54083.html?wbdisable=true","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis: A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Summary SGLT2 inhibitor use was associated with an increased risk of DKA compared to DPP-4 inhibitors among patients with…","rawSnapshotUrl":"/api/snapshots/raw/1350765","browseUrl":"https://replay.healtharchive.ca/job-8/20260219200619/https://cihr-irsc.gc.ca/e/54083.html?wbdisable=true#ha_snapshot=1350765","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}